This week in gene and cell therapy - 10 August 2018

Gene and cell therapy headlines 6 - 10 August

Oxford Biomedica and Boehringer Ingelheim to partner with UK Cystic Fibrosis Gene Therapy Consortium

EvolvR, a new CRISPR based system, drives locus specific mutagenesis

Regeneron and Bluebird bio enter partnership to develop anti-cancer cell therapies

Akouos raises funds to take gene therapy for hearing loss into the clinic

Spark releases data from haemophilia a trial and aims to move into phase 3

Allergan to co-develop and co-commercialise Editas gene therapy for retinal disorder

Sarepta acquires rights to Lacerta Therapeutics CNS gene therapy

Regenxbio releases promising phase I data for wet AMD gene therapy

Astellas increases gene therapy presence by acquiring Quethera